Aplantex highlights with satisfaction having exceeded its bridge financing target in 2025, closing at 5M$. ” We are delighted that the relevance of our past, current, and planned strategic initiatives is recognized by the growing commitment of our early investors, including François Ravenelle, lead investor in this bridge round, and our main partners, led by Investissement Québec. This support energizes the Aplantex team. Ongoing R&D projects are on track to meet the requirements of our current national and international clients, and exciting new initiatives are designed to improve the efficiency of Aplantex’s unique green biotechnology process and reduce the selection time for relevant variations of our proprietary photosynthetic phytoreplicators. Our progression is gaining traction as the innovation center is expanding to include an industrial-grade pilot plant. Mr. Patrick Charest, B.Sc., Eng., mMBA, CEO.

This exciting upshot fuels our progression from a research-focused company to a production-oriented company.

“This bridge financing is an important step, allowing the company to pivot from a research-focused company to a production-oriented company, creating exciting new opportunities for the Company and for its growth”, said François Ravenelle, Ph.D., Lead Investor and Aplantex Board member.

Aplantex’s innovative green biotechnology process offers a solution that will help key industries circumvent the increasing disruptions in their supply chain, increase their productivity, and significantly reduce their environmental footprint. The support of Investissement Québec for young innovative companies launching new initiatives in the market and contributing to making their industries greener and more sustainable is very valuable to us.

SEE THE PRESS RELEASE

Share : Back to blog